Patient-reported outcome measures improve survival risk and quality of life for cancer patients, according to a study published Aug. 13 in JAMA Network Open. PROMs are self-reported statements from ...

Researchers develop a new patient-reported outcome measure that may help assess how obesity or overweight, and their ...

Financial Distress in Genitourinary Cancer: Insights From CDC National Health Interview Survey Patient-reported outcomes (PROs) information has been routinely collected in Cancer Care Alberta (CCA) ...

Providing the best patient-centered care, as measured by the individual patient's perceived value of care at a reasonable cost, has become the established definition of value-based health care (VBHC).

Please provide your email address to receive an email when new articles are posted on . Historically, patient-reported outcome measures were primarily used for research. Today, surgeons use ...

Please provide your email address to receive an email when new articles are posted on . CMS established a policy to standardize PROMs collection and reporting. There are several barriers to PROMs data ...

Patient-reported outcome measures utilising a symptom questionnaire do not appear to expedite how quickly diagnosed depression symptoms dissipate nor do they improve overall social functioning or ...

Patient-reported outcomes (PROs) have rapidly become integral to cancer care, offering invaluable insights by capturing the patient’s perspective on symptoms, quality of life, and treatment-related ...

This is a preview. Log in through your library . Abstract Purpose Patient-reported outcome measures (PROMs) are standardized instruments used to collect data about the subjective assessment of medical ...

Patient-reported outcome measures (PROMs) are crucial tools for assessing the health and well-being of children, yet their application in pediatrics faces unique challenges due to developmental ...

Analysis of the phase 3 explorer7 (NCT04083781) study indicates a preference for concizumab prophylaxis over no prophylaxis in patients with hemophilia A or B with inhibitors. Among individuals with ...